These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25183504)

  • 1. Effect of ranolazine on cardiac microcirculation in normal and diabetic rats.
    Khazraei H; Shafa M; Mirkhani H
    Acta Physiol Hung; 2014 Sep; 101(3):301-8. PubMed ID: 25183504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application.
    Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA
    J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):125-33. PubMed ID: 19329672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant effect of ranolazine on isolated normal and diabetic rat aorta: a study of possible mechanisms.
    Khazraei H; Mirkhani H; Purkhosrow A
    Acta Physiol Hung; 2013 Jun; 100(2):153-62. PubMed ID: 23708946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of ranolazine on cardiac function after myocardial infarction are greater in diabetic than in nondiabetic rats.
    Mourouzis I; Mantzouratou P; Galanopoulos G; Kostakou E; Dhalla AK; Belardinelli L; Pantos C
    J Cardiovasc Pharmacol Ther; 2014 Sep; 19(5):457-69. PubMed ID: 24651516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model.
    Nieminen T; Tavares CA; Pegler JR; Belardinelli L; Verrier RL
    Circ Cardiovasc Interv; 2011 Oct; 4(5):481-7. PubMed ID: 21953372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model.
    Nieminen T; Nanbu DY; Datti IP; Vaz GR; Tavares CA; Pegler JR; Nearing BD; Belardinelli L; Verrier RL
    Heart Rhythm; 2011 Apr; 8(4):608-14. PubMed ID: 21094698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
    Carvas M; Nascimento BC; Acar M; Nearing BD; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):286-91. PubMed ID: 20075744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
    Kloner RA; Dow JS; Bhandari A
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):192-6. PubMed ID: 21193683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.
    Heidarianpour A; Hajizadeh S; Khoshbaten A; Niaki AG; Bigdili MR; Pourkhalili K
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):746-52. PubMed ID: 18043294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.
    Zacharowski K; Blackburn B; Thiemermann C
    Eur J Pharmacol; 2001 Apr; 418(1-2):105-10. PubMed ID: 11334871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sildenafil citrate (Viagra) on coronary flow in normal subjects.
    Ishikura F; Beppu S; Ueda H; Nehra A; Khandheria BK
    Echocardiography; 2008 Jan; 25(1):72-6. PubMed ID: 18186782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and hepatic microcirculational changes in endotoxemic rats treated with different NOS inhibitors.
    Hwang TL; Yeh CC
    Hepatogastroenterology; 2003; 50(49):188-91. PubMed ID: 12630020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiological effects of ranolazine and lidocaine on normal and diabetic rat atrium.
    Khazraei H; Mirkhani H; Shabbir W
    J Interv Card Electrophysiol; 2021 Apr; 60(3):387-394. PubMed ID: 32328860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term supplementation of vitamin C on pulpal blood flow in streptozotocin-induced diabetic rats.
    Amatyakul S; Chakraphan D; Chotpaibulpan S; Patumraj S
    Clin Hemorheol Microcirc; 2003; 29(3-4):313-9. PubMed ID: 14724356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion.
    Dehina L; Descotes J; Chevalier P; Bui-Xuan B; Romestaing C; Dizerens N; Mamou Z; Timour Q
    Fundam Clin Pharmacol; 2014 Jun; 28(3):257-67. PubMed ID: 23607936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.